Skip Navigation


Rheumatology Advance Access originally published online on July 9, 2009
Rheumatology 2009 48(9):1179; doi:10.1093/rheumatology/kep186
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/9/1179    most recent
kep186v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Luqmani, R.
Right arrow Articles by Deighton, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luqmani, R.
Right arrow Articles by Deighton, C.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Comment on: British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years): reply

Raashid Luqmani1,2, Susan Oliver3, Ailsa Bosworth4, Dawn Homer5 and Chris Deighton6

1Department of Rheumatology, Nuffield Orthopaedic Centre, 2Biomedical Research Unit, Botnar Research Centre, University of Oxford, Oxford, 3Royal College of Nursing, London, 4National Rheumatoid Arthritis Society, Maidenhead, 5Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham and 6Rheumatology Department, Derbyshire Royal Infirmary, Derby, UK

Correspondence to: Raashid Luqmani, Department of Rheumatology, Nuffield Orthopaedic Centre, Windmill Road, Oxford, OX3 7LD, UK. E-mail: Raashid.luqmani@noc.nhs.uk

The first 10% of the full text of this article appears below.

SIR, We thank McLaren and colleagues [1] for raising a difficult issue, which we all wrestled with when developing the BSR/BHPR guidelines [2] and also with the recently published NICE RA Guidelines [3]. The issue over what constitutes optimal treatment is an ongoing area of concern for all. It has been . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?